Exploring Treatment Strategies to Improve Outcomes in the Management of Narcolepsy

A continuing medical education activity sponsored by NAMCP and AAMCN.

This activity is an archive from the live session from the 2019 Fall Managed Care Forum. If you participated in the live session, you are not eligible for continuing education credits from this archive.

This activity is valid from January 1, 2020 to January 1, 2021

Instructions for CME/CNE: Complete the pre-test, listen to the audio and view the slides, complete the post test, complete the evaluation form and hit submit. You will be asked to enter your name and email address on the pre-test, evaluation and post-test. If you close your internet browser without completing the post test, you will have ONE more opportunity to complete. A score of 70% must be achieved on the post test to receive continuing education credits. If you do not pass the post test after two attempts, you will not be eligible to try again. Once you complete the evaluation form and score 70% or higher on your post test, you will automatically be given your certificate.

To print or save your certificate, you will need to click on the “download” button and either print or save.


Audience: This activity is intended for healthcare professionals practicing in managed care environments.

This presentation is supported by an educational grant from
Jazz Pharmaceuticals

Narcolepsy is a chronic disorder of hypersomnia that affects the brain’s ability to control sleep-wake cycles. Patients with narcolepsy, experience severe excessive daytime sleepiness (EDS), sleep paralysis, hallucinations, and cataplexy which is the most specific symptom and occurs in almost no other diseases. Narcolepsy leads to involuntary somnolence during regular activities that potentially put the patient and others in harmful situations, such as driving, eating, or talking. Narcolepsy often interferes with psychological, social, and cognitive function and development and interferes with academic studies, work, and social activities. It is important for clinicians to understand and identify major sleep disorders and having greater awareness of the disorder and its symptoms can help accurately and efficiently diagnosis the disease. The combination of an overnight polysomnogram (PSG) followed by a multiple sleep latency test (MSLT) can provide the proper evidence of narcolepsy while excluding other sleep disorders. An MRI can also show structural abnormalities of the brain that may assist in depicting the underlying cause of the syndrome. Treatment of narcolepsy includes both nonpharmacologic and pharmacologic components and most patients improve if they maintain a regular sleep schedule. Pharmacologic treatment of narcolepsy involves the use of stimulants to the central nervous system such as methylphenidate, modafinil, dextroamphetamine sulfate, methamphetamine, and amphetamine. These medications help reduce daytime sleepiness, improving the symptoms in around 70% of patients. In addition, novel treatment options, such as solriamfetol, are currently undergoing clinical trials and are awaiting approval by the FDA.

Upon completion of this activity, participants will be able to:

  • Analyze the current recommended guidelines and current evidence of emerging agents in the treatment of narcolepsy

  • Discuss the current diagnostic criteria and the importance of early and accurate diagnosis in patients with narcolepsy

  • Assess newer pharmacologic treatments for narcolepsy based on efficacy, safety, and cost data

  • Examine the use of shared decision-making strategies to coordinate care for narcolepsy among a multidisciplinary team

Faculty: Richard K. Bogan, MD, FCCP, FAASM
Chief Medical Officer, SleepMed, Inc.
Clinical Associate Professor
Medical University of South Carolina


Dr. Bogan has served on an advisory board for Harmony and Jazz. He has received grant/research support from Axsome, Balance, Harmony and Jazz. He serves on the speaker's bureau for Jazz and Merck. His presentation has been reviewed for any bias.
  Planning Committee:
Bill Williams, MD has no relevant financial relationships to disclose.
Jeremy Williams has no relevant financial relationships to disclose.
Will Williams has no relevant financial relationships to disclose.
Jacqueline Cole, RN, MS, CMCN has no relevant financial relationships to disclose.

NAMCP and/or the presenter has copyright or has received permissions for use of materials provided in this activity.

Accreditation & Designation
The National Association of Managed Care Physicians (NAMCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

NAMCP designates this enduring material for a maximum of 1 AMA PRA Category 1 creditsTM.

The American Association of Managed Care Nurses (AAMCN) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Nurses who complete this activity and achieve a passing score will receive 1 hour in continuing
nursing credit.

This activity has been approved by the American Board of Managed Care Nursing for 1.0 contact hour toward CMCN recertification requirements.

This presentation is supported by an educational grant from
Jazz Pharmaceuticals

NAMCP and/or this website does not provide medical advice, diagnosis or treatment. NAMCP does not endorse or imply endorsement of the content on any linked website. This website is to be used as an informational resource. With any health related concern, consult with your physician or healthcare professional.

Click Here To Continue